Law360 (June 24, 2021, 4:04 PM EDT) -- Medical productivity business Doximity Inc. was one of at least three health care and life sciences-focused companies that began trading Thursday, after pricing a $606 million initial public offering that was guided by Goodwin and Cooley.
In addition to San Francisco-based Doximity's upsized offering, biotechnology companies Monte Rosa Therapeutics Inc. raised about $222.3 million and Miromatrix Medical Inc. priced a $43.2 million IPO, according to separate statements.
Monte Rosa is also represented by Goodwin Procter LLP and its underwriters are advised by Latham & Watkins LLP. Miromatrix is represented by Faegre Drinker Biddle & Reath LLP and its underwriters are guided...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!